medRxivGenetic & Genomic MedicinePreprint
A Compendium of manually annotated genetic variants for Alkaptonuria-AKUHub
S Akila, Tannavee KumariD, Shofia Saghya Infant, S Srividya, N Suriyamoorthy, R Vijhayalakshmi, Vinod ScariaiD, Ratnesh Bhai Mehta
- Citations
- 0
Abstract
1.Alkaptonuria or black urine disease is a rare autosomal recessive disorder caused by dysfunctional homogentisate 1,2-dioxygenase (HGD) gene (3q13.33) leading to accumulation of homogentisic acid in the body. This inborn error in metabolism of phenylalanine and tyrosine causes accumulation of homogentisic acid leading to ochronosis, pigmentation in the sclera, ear cartilage, mitral valve calcification and osteoarthropathy. Advances in sequencing technologies have helped us to map genetic variants associated with alkaptonuria in diverse populations and regions. Currently, no centralized resource of all the reported actionable variants with uniformity in annotation exists for the HGD gene. We have compiled HGD exonic variants from various data sources and systematically annotated their pathogenicity according to American College of Medical Genetics and the Association of Molecular Pathologists (ACMG/AMP) variant classification framework. A total of 1686 exonic variants were catalogued and manually curated, creating one of the most comprehensive Alkaptonuria variant databases (AKUHub) which is publicly available.
- organism: human
- assay: whole-exome sequencing
- research focus: database / resource
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HGDiscovery: an online tool providing functional and phenotypic information on novel variants of homogentisate 1,2- dioxigenase
Malancha Karmakar, Vittoria Cicaloni, … David Benjamin Ascher·Current Research in Structural BiologyPeer-reviewed·Jan 1, 2022
- Studies in alkaptonuria reveal new roles beyond drug clearance for phase I and II biotransformations in tyrosine metabolism
B. P. Norman, A. S. Davison, … J. A. Gallagher·bioRxiv·Apr 16, 2020
- Unraveling the metabolic landscape of alkaptonuria through a human-relevant in vitro liver disease model
Matthias Rombaut, Gigly G. Del’haye, … Joery De Kock·bioRxiv·Sep 29, 2026
- An anatomical investigation of alkaptonuria: Novel insights into ochronosis of cartilage and bone
Juliette H. Hughes, Gemma Charlesworth, … Alistair P. Bond·Journal of AnatomyPeer-reviewed·Dec 20, 2024
- Liver-directed AAV gene therapy metabolically corrects AKU in Hgd deficient mice
Sien Lequeue, Brendan P. Norman, … Joery De Kock·bioRxiv·Jun 2, 2026
- Deciphering and Improving Human Homogentisate 1,2-Dioxygenase Function Through Knowledge Gaining Directed Evolution: Implications for Alkaptonuria
Sien Lequeue, Jessie Neuckermans, … Joery De Kock·International Journal of Biological MacromoleculesPeer-reviewed·Aug 28, 2026